首页 > 市场调查报告书 > 食物/饮料

生鲜食品

市场调查报告书

商品编码

1386381

水产养殖疫苗市场报告：2030 年趋势、预测与竞争分析

Aquaculture Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: 2023年10月03日 | 出版商:

Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

水产养殖疫苗的趋势与预测

2030年，全球水产养殖疫苗市场预计将达到7亿美元，2024年至2030年的年复合成长率为7.6%。该市场的主要驱动因素是对水生动物食品的需求增加、水产养殖部门感染疾病的显着增加以及水产养殖产量的扩大。全球水产养殖疫苗市场前景广阔，灭活疫苗和DNA疫苗市场蕴藏商机。

水产养殖疫苗市场洞察

Lucintel 广泛用于水生动物，作为多种疾病的预防措施，包括水肿、弧菌病、冷水弧菌病、冬腐病、IPN 和鲑鱼传染性贫血(ISA)，使其成为一种注射药物。我们预测它将继续成为一个更大的细分市场。

亚太地区预计将在预测期内实现最高成长，因为它是该地区最大的水产养殖业之一。

本报告回答了 11 个关键问题：

Q.1. 细分市场中最有前途和高成长的机会是什么？
Q.2.哪个细分市场将以更快的速度成长？为什么？
Q.3.您认为哪些地区未来会出现更快的成长？为什么？
Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
Q.5. 这个市场的商业风险和竞争威胁是什么？
Q.6.这个市场有哪些新趋势？为什么？
Q.7.市场客户需求有何改变？
Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

成长机会分析
- 全球水产养殖疫苗市场成长机会（按产品）
- 按给药途径分類的全球水产养殖疫苗市场成长机会
- 全球水产养殖疫苗市场成长机会（按地区）
全球水产养殖疫苗市场的新趋势
战略分析
- 新产品开发
- 扩大全球水产养殖疫苗市场产能
- 全球水产养殖疫苗市场的合併、收购与合资企业
- 认证和许可

第7章主要企业概况

GlaxoSmithKline
Merck
Pfizer
Sanofi
CSL
Emergent BioSolutions
Johnson & Johnson
AstraZeneca
Serum Institute of India
Bavarian Nordic

简介目录

Aquaculture Vaccine Trends and Forecast

The future of the global aquaculture vaccine market looks promising with opportunities in the inactivated and dna markets. The global aquaculture vaccine market is expected to reach an estimated $0.7 billion by 2030 with a CAGR of 7.6% from 2024 to 2030. The major drivers for this market are increasing demand for food products derived from aquatic animals, notable rise in infectious diseases within the aquaculture sector, and expansion of aquaculture production.

A more than 150-page report is developed to help in your business decisions.

Aquaculture Vaccine by Segment

The study includes a forecast for the global aquaculture vaccine by product, route of administration, and region.

Aquaculture Vaccine Market by Product [Shipment Analysis by Value from 2018 to 2030]:

Inactivated Vaccines
DNA Vaccines

Aquaculture Vaccine Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:

Injected
Oral

Aquaculture Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

North America
Europe
Asia Pacific
The Rest of the World

List of Aquaculture Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies aquaculture vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the aquaculture vaccine companies profiled in this report include-

GlaxoSmithKline
Merck
Pfizer
Sanofi
CSL
Emergent BioSolutions
Johnson & Johnson
AstraZeneca
Serum Institute of India
Bavarian Nordic

Aquaculture Vaccine Market Insights

Lucintel forecasts that injected will remain the larger segment due to its widespread use in aquatic animals as a preventative measure against a number of illnesses, including as furunculosis, vibriosis, cold-water vibriosis, winter sore, IPN, and infectious salmon anemia (ISA).

APAC is expected to witness highest growth over the forecast period due to the presence of one of the region's largest aquaculture industries in the region.

Features of the Global Aquaculture Vaccine Market

Market Size Estimates: Aquaculture vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Aquaculture vaccine market size by product, route of administration, and region in terms of value ($B).

Regional Analysis: Aquaculture vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, route of administrations, and regions for the aquaculture vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the aquaculture vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the aquaculture vaccine market size?

Answer: The global aquaculture vaccine market is expected to reach an estimated $0.7 billion by 2030.

Q.2 What is the growth forecast for aquaculture vaccine market?

Answer: The global aquaculture vaccine market is expected to grow with a CAGR of 7.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the aquaculture vaccine market?

Answer: The major drivers for this market are increasing demand for food products derived from aquatic animals, notable rise in infectious diseases within the aquaculture sector, and expansion of aquaculture production.

Q4. What are the major segments for aquaculture vaccine market?

Answer: The future of the aquaculture vaccine market looks promising with opportunities in the inactivated and dna markets.

Q5. Who are the key aquaculture vaccine market companies?

Answer: Some of the key aquaculture vaccine companies are as follows:

GlaxoSmithKline
Merck
Pfizer
Sanofi
CSL
Emergent BioSolutions
Johnson & Johnson
AstraZeneca
Serum Institute of India
Bavarian Nordic

Q6. Which aquaculture vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that injected will remain the larger segment due to its widespread use in aquatic animals as a preventative measure against a number of illnesses, including as furunculosis, vibriosis, cold-water vibriosis, winter sore, IPN, and infectious salmon anemia (ISA).

Q7. In aquaculture vaccine market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to the presence of one of the region's largest aquaculture industries in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the aquaculture vaccine market by product (inactivated vaccines and DNA vaccines), route of administration (injected and oral), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

1. Executive Summary

2. Global Aquaculture Vaccine Market : Market Dynamics

2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Aquaculture Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Aquaculture Vaccine Market by Product
- 3.3.1: Inactivated Vaccines
- 3.3.2: DNA Vaccines
3.4: Global Aquaculture Vaccine Market by Route of Administration
- 3.4.1: Injected
- 3.4.2: Oral

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

4.1: Global Aquaculture Vaccine Market by Region
4.2: North American Aquaculture Vaccine Market
- 4.2.2: North American Aquaculture Vaccine Market by Route of Administration: Injected and Oral
4.3: European Aquaculture Vaccine Market
- 4.3.1: European Aquaculture Vaccine Market by Product: Inactivated Vaccines and DNA Vaccines
- 4.3.2: European Aquaculture Vaccine Market by Route of Administration: Injected and Oral
4.4: APAC Aquaculture Vaccine Market
- 4.4.1: APAC Aquaculture Vaccine Market by Product: Inactivated Vaccines and DNA Vaccines
- 4.4.2: APAC Aquaculture Vaccine Market by Route of Administration: Injected and Oral
4.5: ROW Aquaculture Vaccine Market
- 4.5.1: ROW Aquaculture Vaccine Market by Product: Inactivated Vaccines and DNA Vaccines
- 4.5.2: ROW Aquaculture Vaccine Market by Route of Administration: Injected and Oral

5. Competitor Analysis

5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

6.1: Growth Opportunity Analysis
- 6.1.1: Growth Opportunities for the Global Aquaculture Vaccine Market by Product
- 6.1.2: Growth Opportunities for the Global Aquaculture Vaccine Market by Route of Administration
- 6.1.3: Growth Opportunities for the Global Aquaculture Vaccine Market by Region
6.2: Emerging Trends in the Global Aquaculture Vaccine Market
6.3: Strategic Analysis
- 6.3.1: New Product Development
- 6.3.2: Capacity Expansion of the Global Aquaculture Vaccine Market
- 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Aquaculture Vaccine Market
- 6.3.4: Certification and Licensing